NO921159D0 - Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer - Google Patents

Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer

Info

Publication number
NO921159D0
NO921159D0 NO921159A NO921159A NO921159D0 NO 921159 D0 NO921159 D0 NO 921159D0 NO 921159 A NO921159 A NO 921159A NO 921159 A NO921159 A NO 921159A NO 921159 D0 NO921159 D0 NO 921159D0
Authority
NO
Norway
Prior art keywords
derivatives
tiazolidinon
oxsazolidinon
vasodilators
procedures
Prior art date
Application number
NO921159A
Other languages
English (en)
Other versions
NO304311B1 (no
NO921159L (no
Inventor
Sadao Ishihara
Fujio Saito
Takao Yoshioka
Hiroyuki Koike
Sigeki Miyake
Hiroshi Mizuno
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO921159D0 publication Critical patent/NO921159D0/no
Publication of NO921159L publication Critical patent/NO921159L/no
Publication of NO304311B1 publication Critical patent/NO304311B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Indole Compounds (AREA)
NO921159A 1991-03-27 1992-03-25 Tiazolidinon- og oksazolidinonderivater og farmas°ytisk preparat NO304311B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6308891 1991-03-27
JP10275191 1991-05-08
JP33030491 1991-12-13

Publications (3)

Publication Number Publication Date
NO921159D0 true NO921159D0 (no) 1992-03-25
NO921159L NO921159L (no) 1992-09-28
NO304311B1 NO304311B1 (no) 1998-11-30

Family

ID=27298042

Family Applications (1)

Application Number Title Priority Date Filing Date
NO921159A NO304311B1 (no) 1991-03-27 1992-03-25 Tiazolidinon- og oksazolidinonderivater og farmas°ytisk preparat

Country Status (23)

Country Link
US (2) US5298516A (no)
EP (1) EP0506434B1 (no)
JP (1) JPH0780859B2 (no)
KR (1) KR0152097B1 (no)
CN (2) CN1031824C (no)
AT (1) ATE118770T1 (no)
AU (1) AU647599B2 (no)
CA (1) CA2064108C (no)
CZ (1) CZ282529B6 (no)
DE (1) DE69201451T2 (no)
DK (1) DK0506434T3 (no)
ES (1) ES2072095T3 (no)
FI (1) FI106260B (no)
HK (1) HK123595A (no)
HU (2) HU217969B (no)
IE (1) IE67383B1 (no)
IL (1) IL101395A (no)
IS (1) IS1746B (no)
NO (1) NO304311B1 (no)
NZ (1) NZ242154A (no)
PH (1) PH30493A (no)
RU (1) RU2055073C1 (no)
TW (1) TW226015B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3454531B2 (ja) * 1991-11-07 2003-10-06 三共株式会社 ニトロキシアルキルアミド誘導体
CA2158368A1 (en) * 1993-03-15 1994-09-29 Jan Bron Use of substituted alkyl nitrates for the treatment of pathologically raised intraocular pressure
DE4429461A1 (de) * 1994-08-19 1996-02-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
MX9704435A (es) * 1994-12-15 1997-10-31 Sankyio Company Ltd Compuestos de tiazolidinona y agente terapeutico o agente de prevencion para angina de pecho, que comprende los compuestos como un ingrediente activo.
HU223094B1 (hu) * 1995-03-02 2004-03-29 Sankyo Co., Ltd. Optikailag aktív tiazolidinonszármazékok, előállításuk, a vegyületeket hatóanyagként tartalmazó gyógyászati készítmények és tia-vagy oxazolidinonszármazékok alkalmazása gyógyászati készítmények előállítására
US5925658A (en) * 1995-03-02 1999-07-20 Sankyo Company, Limited Optically active thiazolidinone derivative
WO1997000239A1 (fr) * 1995-06-14 1997-01-03 Sankyo Company, Limited Medicament contre l'angine contenant un derive nitroxy comme ingredient actif
BE1010768A3 (nl) * 1996-11-26 1999-01-05 Dsm Nv Een werkwijze voor de bereiding van alpha-aminozuuramiden, alpha-aminozuren en derivaten ervan.
IL120531A (en) 1997-03-26 2006-12-31 Yissum Res Dev Co Nitric oxide donors and pharmaceutical compositions containing them
WO2002069967A1 (fr) * 2001-03-01 2002-09-12 Sankyo Company, Limited Compositions a absorption percutanee
CA2842106A1 (en) * 2011-07-28 2013-01-31 Promentis Pharmaceuticals, Inc. Cysteine prodrugs
US10239847B1 (en) 2016-03-03 2019-03-26 Cellactin Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
GB8717068D0 (en) * 1987-07-20 1987-08-26 Fujisawa Pharmaceutical Co Nitric ester derivative
DE10199034I2 (de) * 1989-04-21 2011-07-21 Ei Du Pont Du Nemours & Co Fungizide oxazolidinone.

Also Published As

Publication number Publication date
IE920966A1 (en) 1992-10-07
RU2055073C1 (ru) 1996-02-27
CZ282529B6 (cs) 1997-08-13
HK123595A (en) 1995-08-04
HU9201033D0 (en) 1992-06-29
ES2072095T3 (es) 1995-07-01
IL101395A (en) 1996-10-16
CN1066067A (zh) 1992-11-11
IE67383B1 (en) 1996-03-20
CN1113435A (zh) 1995-12-20
FI921340A (fi) 1992-09-28
CZ91692A3 (en) 1993-01-13
CN1031824C (zh) 1996-05-22
DE69201451D1 (de) 1995-03-30
IL101395A0 (en) 1992-11-15
CA2064108A1 (en) 1992-09-28
FI921340A0 (fi) 1992-03-26
HU211969A9 (en) 1996-01-29
DE69201451T2 (de) 1995-10-12
HU217969B (hu) 2000-05-28
ATE118770T1 (de) 1995-03-15
US5356918A (en) 1994-10-18
FI106260B (fi) 2000-12-29
KR920018036A (ko) 1992-10-21
NZ242154A (en) 1993-09-27
KR0152097B1 (ko) 1998-10-15
HUT68242A (en) 1995-06-28
IS1746B (is) 2000-07-11
DK0506434T3 (da) 1995-07-24
US5298516A (en) 1994-03-29
EP0506434B1 (en) 1995-02-22
AU647599B2 (en) 1994-03-24
PH30493A (en) 1997-05-28
IS3828A (is) 1992-09-28
CN1096265C (zh) 2002-12-18
CA2064108C (en) 2000-09-26
EP0506434A1 (en) 1992-09-30
NO304311B1 (no) 1998-11-30
JPH0780859B2 (ja) 1995-08-30
AU1312292A (en) 1992-10-01
TW226015B (no) 1994-07-01
NO921159L (no) 1992-09-28
JPH05213910A (ja) 1993-08-24

Similar Documents

Publication Publication Date Title
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
PT976748E (pt) Derivados de pirrolidina com actividade inibidora de fosfolipase a2
JPS568361A (en) Pyroglutamic acid derivative and analogue
HK1011967A1 (en) Amide derivatives having anti-hyper cholesteremic activity their preparation and their therapeutic uses
ES2078654T3 (es) Analogos de atp.
NO921159D0 (no) Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer
DK0916651T3 (da) Phenylalkylcarboxylsyrederivater
NO852514L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-alkyltio-2-piperazino-pyrimido (5,4-d) pyrimidin-derivater.
HUT75647A (en) Imidazolidinone derivatives and pharmaceutical compositions containing them, which are suitable for treament of senile dementia
AU4271389A (en) Phenylalkyl or phenylalkoxyethyl substituted piperazine derivatives
DK424888A (da) Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees